PNEUMOCOCCAL IMMUNIZATION
Clinical trials for PNEUMOCOCCAL IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL IMMUNIZATION trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for babies aims to block more pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a new version of a vaccine that protects against serious bacterial infections like pneumonia and meningitis. It will compare the safety and immune response of the new 21-strain vaccine against a currently licensed 20-strain vaccine in healthy infants. Babies…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC
-
New vaccine for babies aims to protect against more pneumonia strains
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing the safety of a new pneumococcal vaccine (PCV21) designed to protect against 21 strains of bacteria that can cause pneumonia, meningitis, and ear infections. It will compare the new vaccine to an already approved 20-strain vaccine in about 2,320 healthy infa…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Phase: PHASE3 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
Pfizer tracks Real-World vaccine safety in korean population
Knowledge-focused Recruiting nowThis study aims to monitor the safety of the Prevenar 20 pneumococcal vaccine in routine medical practice in Korea. It will enroll 660 participants aged 6 weeks and older who receive the vaccine as part of their normal healthcare. Researchers will track any side effects or reacti…
Matched conditions: PNEUMOCOCCAL IMMUNIZATION
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC